In 2019, the World Health Organization formally recommended the drug dolutegravir (DTG) as the preferred antiretroviral therapy (ART) for people living with HIV in low and middle-income countries (LMICs), citing that it is more effective and tolerable, less costly, and less prone to developing drug resistance than the previously recommended first-line treatment efavirenz (EFV).
Slow recovery from concussion? Exercise, breathing practice may improve symptoms
Breathing practice as well as gradual aerobic exercise may help improve concussion symptoms in teens experiencing slow recovery, according to a preliminary study released today, February 21, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023. The study found that while the two therapies are each beneficial separately, when combined they resulted in even greater improvement in thinking and memory skills, depression and mood.
Population-scaled, school-based physical activity intervention can help prevent childhood obesity
A new Slovenian population-scaled, school-based study shows that by providing additional physical education lessons to young children is effective in preventing childhood obesity, according to findings published in Obesity, The Obesity Society’s (TOS) flagship journal.
Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding
A monthly vaginal ring containing the antiretroviral drug dapivirine—an HIV prevention method that has been approved in several African countries and recommended by the World Health Organization (WHO) –appears to be safe when used during breastfeeding, suggest results of a Phase IIIb open-label study presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle.
Fast-dissolving insert found safe, shows promise as method for preventing HIV through anal sex
A fast-dissolving insert being developed as an “on-demand” HIV prevention method was found to be safe and well-tolerated in the first study of its use rectally. The results, which were presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle, also found the insert delivered high levels of the anti-retroviral drugs tenofovir alafenamide (TAF) and elvitegravir (EVG) to rectal tissue and fluid, with very little drug circulating elsewhere in the body, and results of laboratory tests suggesting the insert could potentially provide protection for up to three days after use.
FDA Wants To Make Opioid Overdose Antidote Accessible To Many People
Advisory committee members voted unanimously to make Narcan nasal spray available over the counter.
Ozempic Weight Loss: Interested Population Struggles To Afford $1,500 Medication
The weight loss wonder drug continues to witness skyrocketing demand amid the craze.
Bird Flu Has 56% Fatality Rate In Humans; Experts Bracing For Next Pandemic
The virus responsible for the worst bird flu outbreak in the U.S. could develop mutations for easier human transmission.
Any regular physical activity at any age linked to better brain function in later life
Any regular leisure time physical activity at any age is linked to better brain function in later life, but maintaining an exercise routine throughout adulthood seems to be best for preserving mental acuity and memory, suggests a long term study published online in the Journal of Neurology Neurosurgery & Psychiatry.
Celebrity tweets likely shaped US negative public opinion of COVID-19 pandemic, finds study
Tweets by people in the public eye likely increasingly shaped negative public opinion of the COVID-19 pandemic as it progressed in the US, suggests an analysis of sentiments expressed in social media posts, published in the open access journal BMJ Health & Care Informatics.